NCT02216461View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2006

Conditions
Healthy
Interventions
DRUG

Low dose of BIBW 2948 BS for oral inhalation

DRUG

Medium dose of BIBW 2948 BS for oral inhalation

DRUG

High dose of BIBW 2948 BS for oral inhalation

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02216461 - Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter